Figure 3.

In vivo treatment of solid tumors. (a) Tumor growth inhibition in mice treated with RBC-NP(DOX), free DOX, RBC-NP, or isotonic sucrose by tail vein injection (n = 5). Treatment was initiated 9 days post-challenge, and mice were administered formulations every other day for 2 weeks. (b) Survival of mice treated with RBC-NP(DOX), free DOX, RBC-NP, or isotonic sucrose. (c) Relative weights of tumor-bearing mice treated with RBC-NP(DOX), free DOX, RBC-NP, or isotonic sucrose. Values were normalized within each group using the measurements on day 0.